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Current guidelines for the assessment of aortic stenosis
severity are based upon echocardiographic measurements of
the peak velocity, the mean gradient, and the aortic valve
area (AVA) (often indexed to body surface area). Thereafter,
the decision to proceed to aortic valve replacement is largely
governed by the presence of symptoms in those with severe
disease. Although these guidelines are useful in the majority
of patients, an important limitation to this model has been
elegantly described in this issue of the Journal.
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In this large multicenter study, Clavel et al. (1) assessed
646 patients with moderate or severe aortic stenosis and
preserved ejection fraction, all of whom underwent com-
prehensive echocardiographic evaluation. This revealed that,
in almost one-third of patients (n ¼ 186), there was
a discordance in the classiﬁcation of aortic stenosis severity:
most commonly (n ¼ 172) characterized by a tight AVA
(<1.0 cm2) in the context of a relatively low mean gradient
(<40 mm Hg). This would suggest that, in a signiﬁcant
proportion of patients, uncertainty exists as to whether they
have moderate or severe stenosis, with such a distinction
potentially crucial in determining appropriate clinical man-
agement and the need for surgery.
So what is the explanation for this discrepancy? Data from
the current study provide some clues. It is unlikely to reﬂect
the study population or an effect of patient size, because
values for AVA were indexed to body surface area. We can
be reasonably reassured that it is unlikely to reﬂect subop-
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ﬁndings occur frequently in all cardiac centers and are
a common experience for most clinical cardiologists. Low-
ﬂow severe aortic stenosis has been previously described in
patients with low stroke volumes with and without im-
paired systolic function (2). However, all patients in this
study had a normal ejection fraction (>50%), and low ﬂow
(deﬁned as an SVi <35 ml/m2) was observed in just 25
subjects, leaving the vast majority (n ¼ 147) with a normal
ﬂow status.
As the authors indicate, reduced aortic compliance might
have a role. However, the simplest explanation might instead
lie in the severity thresholds chosen for each of the different
echocardiographic parameters. These are largely historical
and derived from cardiac catheterization data that are not
directly comparable to echocardiographic measurements.
Moreover, the thresholds selected in the guidelines have
inherent inconsistencies, with theoretical models indicating
that an aortic valve area of 1 cm2 relates more to a mean
gradient of 30 to 35 mm Hg rather than the 40 mmHg used
in the guidelines.
Alternatively, the answer might relate to the tendency of
echocardiography to underestimate the left ventricular out-
ﬂow tract (LVOT) diameter. Alongside the pre- and post-
valve Doppler data, this represents an integral component
of the continuity equation and therefore a key inﬂuence
on AVA measurements. With the advent of transcutaneous
aortic valve replacement, greater focus has been placed on how
best to size the LVOT. Contrast-enhanced computed to-
mography has clearly demonstrated that this structure is not
circular but oval, so that echocardiographic measurements on
parasternal long-axis views frequently underestimate its true
size (3). As a consequence, AVA measurements might also
be underestimated in patients with a particularly elliptical
LVOT.
Whatever the explanation, perhaps the more important
question is what should we do to resolve this discrepancy?
The authors of the current study adopted an interesting
approach: turning to computed tomography (CT) calcium
scoring as a second method of disease severity assessment.
First, they studied the patients in whom the classiﬁcation of
aortic stenosis severity was not in doubt to determine the
CT calcium score that best differentiated moderate from
severe aortic stenosis. Male patients with severe disease had
signiﬁcantly higher AV calcium scores than female patients,
so that sex-speciﬁc thresholds were required (AVC 1,275
AU in women and 2,065 AU in men). These provided
speciﬁcities and sensitivities for severe aortic stenosis of bet-
ween 80% and 89%. Subsequently, the authors then used
these optimal thresholds to determine whether patients
with discordant echocardiographic measures had moderate
or severe stenosis according to CT. With this approach,
roughly one-half were in the moderate (47%) and one-half
were in the severe group (53%), indicating that CT might
provide useful discrimination in this difﬁcult subgroup of
patients.
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2340Follow-up studies are clearly required to assess whether
the categorization provided by CT accurately identiﬁes those
at high-risk of adverse events; however, this strategy holds
several potential advantages. Firstly, CT calcium scoring is
relatively simple in its approach, easy to conceptualize, and
independent from the confounding effects of volume status,
aortic compliance, and left ventricular function. Put simply,
the more calcium in the valve, the more severe the aortic
stenosis (4). This is in sharp contrast to some of the novel
echocardiographic measures of severity that seem to involve
a large number of variables and assumptions. Secondly,
aortic valve calcium scoring, even when performed in a semi-
quantitative manner, has already demonstrated good predic-
tion of disease progression and adverse events, out-performing
more conventional measures of disease severity (5).
This approach does have some clear limitations. These
include both the availability of CT and the radiation dose
associated with these scans (1 to 3 mSv), although the
former is increasing, and the latter is of lesser relevance to
elderly patients with aortic stenosis. In addition, there are
concerns about the reproducibility of calcium scoring at the
very high levels observed in the valve (this was not addressed
in the study) (6), and this approach does not take into
consideration the hypertrophic response of the left ventricle,
which is highly variable and also likely to contribute to the
development of symptoms and adverse events (7). Finally,
and as discussed, there is a lack of follow-up data to validate
the thresholds in calcium score proposed in this study.
What should we do when confronted with discrepant
echocardiographic ﬁndings in clinical practice? In the ab-
sence of a gold-standard arbitrator, a pragmatic approach
would be to carefully revisit the symptomatic status of the
patient, given that this is the key determinant of the need for
surgery. If necessary, this might include a cautious graded
exercise tolerance test, which can unmask symptoms and
provide a functional assessment of the cardiac response to
physical stress. However, an alternative assessment of their
aortic stenosis severity will often be required, given that
elderly patients often have multiple potential causes for
their symptoms. Calciﬁcation clearly underlies much of
the pathophysiological stiffening of the valve and is the
best predictor of disease progression (5). Therefore, CT or
echocardiographic calcium scoring would seem to be the
prime candidates with which to gain further complementary
noninvasive information about the state of the valve.Further studies are required to investigate other potential
biomarkers, such as brain natriuretic peptide (8), troponin,
the strain pattern on the electrocardiogram (9), and the
presence of myocardial ﬁbrosis on cardiovascular magnetic
resonance (10). However, what is clear is that physicians
should be alert to the potential for discrepancy with
standard echocardiographic assessments and the potential
for the burden of valvular calciﬁcation to help identify those
at most risk. Beware the hard hearted.
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